IL10, renowned for its potent immune and inflammatory suppression properties, is thought to inhibit bone resorption and reduce bone loss 17, but some studies have proved that IL10 is significantly increasing in DM patients 18,19, which also just goes to show that DOP development and its regulatory mechanisms are quite complex. Here, IL10 is linked to diabetes mellitus.